---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-061165"
form_type: "8-K"
ticker: "AVBP"
cik: "0001868279"
company_name: "ArriVent BioPharma, Inc."
filed_at: "2025-06-20T23:59:59+00:00"
generated_at: "2026-05-19T01:54:39.570648+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# ArriVent shareholders elect Yao and Peterson to board, ratify PwC as auditor

## Summary
- Quorum of 73.89% (25.2M shares) present at June 18 annual meeting.
- Zhengbin Yao elected with 22.1M for vs 0.4M withheld; broker non-votes 2.6M.
- Kristine Peterson elected with 21.9M for vs 0.6M withheld; broker non-votes 2.6M.
- Ratification of PwC as FY2025 auditor: 25.0M for, 242 against, 167.5K abstain.

## SEC filing metadata
- accession: 0001104659-25-061165
- form_type: 8-K
- ticker: AVBP
- cik: 0001868279
- company_name: ArriVent BioPharma, Inc.
- filed_at: 2025-06-20T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1868279/000110465925061165/0001104659-25-061165-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1868279/000110465925061165/tm2518556d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-061165
- JSON: https://secwatch.observer/filing/0001104659-25-061165.json
- Plain text: https://secwatch.observer/filing/0001104659-25-061165.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
